Show simple item record

dc.contributor.authorBryant, Zeke
dc.date.accessioned2015-06-12T04:32:04Z
dc.date.available2015-06-12T04:32:04Z
dc.date.issued2014-12
dc.identifier.otherbryant_zeke_201412_ms
dc.identifier.urihttp://purl.galileo.usg.edu/uga_etd/bryant_zeke_201412_ms
dc.identifier.urihttp://hdl.handle.net/10724/31395
dc.description.abstractArtemisinin, a derivative of the plant Artemesia annua, is the key compound used in producing medicines for drug-resistant malaria. Mostly grown by small farmers in East Asia and East Africa, there exists a lack of high-yielding genotypes in the artemesia market. Following successful research at the University of Georgia to produce improved varieties of artemesia, an economic evaluation of producing these varieties was performed. An enterprise budget was created for this analysis and fixed and variable costs were accounted for based on reasonable assumptions. Prices and yields were varied at pessimistic, average, and optimistic levels. Costs, prices, and yields were calculated into a sensitivity analysis to estimate net present values for a five acre farm operated for three years. Average price and average yield show a net present value of $129,416 over three years, signaling artemesia to be an economically viable crop in Georgia and likely across the Southern U.S.
dc.languageeng
dc.publisheruga
dc.rightspublic
dc.subjectArtemesia annua
dc.subjectArtemisinin
dc.subjectEnterprise Budget
dc.subjectMalaria
dc.titleAn economic evaluation of Artemesia annua production
dc.typeThesis
dc.description.degreeMS
dc.description.departmentAgricultural and Applied Economics
dc.description.majorAgricultural Economics
dc.description.advisorGreg Colson
dc.description.committeeGreg Colson
dc.description.committeeMichael Wetzstein
dc.description.committeeHazel Wetzstein


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record